Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | JAI GANESH PHARMACEUTICALS | Awarded | 1 | ₹11.6 L |
| 2 | Schedule 2 | JAI GANESH PHARMACEUTICALS | Awarded | 1 | ₹3.9 L |
Tender Value
₹18.2 L
EMD Value
Exempted
Closing Date
29 Jun 2023, 7:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
RECOMBINANT FOLLITROPHIN ALPHA 1050 TO 1200 IU
4916065
GEM/2023/B/3585315
Two Packet Bid
RECOMBINANT FOLLITROPHIN ALPHA 1050 TO 1200 IU,HUMAN MENOPAUSAL GONADOTROPHIN MULTIDOSE VIAL 1200 I
15 days
Punjab; Jalandhar
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹3
80%
Exempted
29 Jun 2023
18 Jun 2023
29 Jun 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | RECOMBINANT FOLLITROPHIN ALPHA 1050 TO 1200 IU | AS PER TITLE | 150 | VIAL | JALANDHAR CITY | 10 |
| 2 | HUMAN MENOPAUSAL GONADOTROPHIN MULTIDOSE VIAL 1200 IU FOR SC INJ | AS PER TITLE | 150 | VIAL | JALANDHAR CITY | 10 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4916065.pdf
GEM_BID
dglp-re-41_2023-06-18-18-39-41_7cffb972a6aee6109445c4d4b837510a.pdf
BOQ
boq_item_sample_file_2023-06-18-18-39-41_865a88b42f45ed2922d2c73ab0a51359.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .